| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) investing activities | 156,866 | 102,895 |
| Proceeds from issuance of common stock, net | 15,082 | 10,309 |
| Payments of equity issuance costs | 6 | 6 |
| Payments of insurance costs financed by a third-party | 0 | 0 |
| Net cash provided by financing activities | 15,076 | 10,303 |
| Net increase (decrease) in cash and cash equivalents | -29,939 | -18,221 |
| Cash and cash equivalents at beginning of period | 145,691 | - |
| Cash and cash equivalents at end of period | 115,752 | - |
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. (NUVL)